Who is the ceo of nutcracker therapeutics? Emeryville, Calif. – September 23, 2020 – Nutcracker Therapeutics, Inc., a company developing and producing mRNA therapeutics on its proprietary, microfluidic, biochip-based platform, today announced the appointment of Madhavan (“Madhu”) Balachandran, former executive vice president Read more…What does sam deutsch do at nutcracker? Sam Deutsch leads biological research and development at Nutcracker Therapeutics, as Senior Vice President, Research & Early Development. Sam orchestrates the development of Nutcracker’s therapeutics through close interactions between internal R&D, advisors and clinical collaborators.What did pin do before nutcracker? Prior to Nutcracker, Pin held several executive positions where he has led the development of several instrumentation and consumables systems for biotechnology, diagnostics, microfluidics and 3D printing.
Contact us here: [email protected] About Nutcracker Therapeutics . Biotech Company We have engineered a push-button mRNA synthesis and formulation platform. Armed with this high-tech advantage, we will advance mRNA therapeutics into the clinic through strategic partnerships with clinical institutions and pharmaceutical/biotech companies.
About us. Nutcracker Therapeutics is an early stage biotech disrupter founded to develop mRNA-based therapeutic drug products which will be manufactured on our novel ACORN (Automation COntroled